Skip to content

Effectiveness of Ultrasound-Guided Suprascapular Nerve Block Using Dextrose 5% Versus a Mixture of Bupivacaine and Betamethasone in The Treatment of Post-Stroke Hemiplegic Shoulder Pain: a Randomized Placebo-Controlled Trial

Effectiveness of Ultrasound-Guided Suprascapular Nerve Block Using Dextrose 5% Versus a Mixture of Bupivacaine and Betamethasone in The Treatment of Post-Stroke Hemiplegic Shoulder Pain: a Randomized Placebo-Controlled Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202512825266164
Enrollment
90
Registered
2025-12-05
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Nervous System Diseases

Interventions

Dextrose Group
Bupivacaine and Betamethasone Group
Placebo group

Sponsors

Ain Shams University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients were diagnosed as having hemiplegia due to stroke. Pain and limited ROM in the shoulder on the hemiplegic side. Patient with age ranges from 18-65 years from both sexes. Shoulder pain with a minimal score of 4 point or more on a pain visual analog scale (VAS). Ability to understand the Arabic language. Patients are conscious, well cooperated, and willing to be enrolled in the study.

Exclusion criteria

Exclusion criteria: Patients with aphasia or who could not express their pain intensity. History of trauma, surgery or previous injection in the involved shoulder. Pain or limited ROM in the affected shoulder prior to stroke onset. Skin infection at the site of injection. History of allergy to injection agents (local anesthetics or steroids). Uncontrolled neurological or medical condition.

Design outcomes

Primary

MeasureTime frame
Assess and compare the effectiveness of ultrasound-guided SSNB using dextrose 5% versus a mixture of steroid and anesthetic agent for alleviating HSP in stroke patients post intervention.

Secondary

MeasureTime frame
Examine the effects on range of motion. Examine motor recovery. Examine disability and quality of life.

Countries

Egypt

Contacts

Public ContactAya Safar

Lecturer of Rheumatology Rehabilitation and Physical Medicine

Ayahamed@med.asu.edu.eg01101138832

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026